Multiple Myeloma
Showing NaN - NaN of 67
Multiple Myeloma Trial in Worldwide (idecabtagene vicleucel, Lenalidomide, Fludarabine)
Not yet recruiting
- Multiple Myeloma
- idecabtagene vicleucel
- +3 more
-
Gilbert, Arizona
- +107 more
Sep 26, 2023
Multiple Myeloma Trial in Worldwide (Iberdomide, Lenalidomide)
Not yet recruiting
- Multiple Myeloma
-
Orange, California
- +270 more
Apr 11, 2023
Multiple Myeloma Trial in Worldwide (Selinexor, Dexamethasone)
Completed
- Multiple Myeloma
-
Birmingham, Alabama
- +60 more
Jan 24, 2023
Multiple Myeloma Trial in Germany (Teclistamab (Tec), Daratumumab, Dexamethasone)
Recruiting
- Multiple Myeloma
- Teclistamab (Tec)
- +4 more
-
Berlin, Germany
- +8 more
Jan 19, 2023
Multiple Myeloma Trial in Worldwide (Daratumumab, Lenalidomide, Dexamethasone)
Active, not recruiting
- Multiple Myeloma
- Daratumumab
- +2 more
-
Little Rock, Arkansas
- +145 more
Jan 17, 2023
Multiple Myeloma Trial in Worldwide (Daratumumab IV, Lenalidomide, Dexamethasone)
Active, not recruiting
- Multiple Myeloma
- Daratumumab IV
- +3 more
-
Birmingham, Alabama
- +211 more
Jan 17, 2023
Multiple Myeloma Trial in Germany (Allogeneic Stem Cells, carfilzomib/lenalidomide/dexamethasone (KRD),
Not yet recruiting
- Multiple Myeloma
- Allogeneic Stem Cells
- +8 more
-
Freiburg, Baden-Württemberg, Germany
- +31 more
Jan 5, 2023
Real-life Current Standards of Care in Relapsed and/or
Completed
- Multiple Myeloma
- No intervention
-
Tucson, Arizona
- +85 more
Dec 20, 2022
Multiple Myeloma Trial in Worldwide (bb2121, Daratumumab, Pomalidomide)
Active, not recruiting
- Multiple Myeloma
- bb2121
- +8 more
-
Birmingham, Alabama
- +59 more
Dec 13, 2022
Multiple Myeloma Trial in Worldwide (Belantamab mafodotin, Daratumumab, Bortezomib)
Active, not recruiting
- Multiple Myeloma
- Belantamab mafodotin
- +3 more
-
Yuma, Arizona
- +150 more
Dec 9, 2022
Multiple Myeloma Trial in Worldwide (Elranatamab (PF-06863135))
Active, not recruiting
- Multiple Myeloma
- Elranatamab (PF-06863135)
-
Beverly Hills, California
- +75 more
Oct 4, 2022
Multiple Myeloma Trial in Worldwide (Belantamab mafodotin, Bortezomib, Lenalidomide)
Recruiting
- Multiple Myeloma
- Belantamab mafodotin
- +3 more
-
Yuma, Arizona
- +34 more
Jul 22, 2022
Multiple Myeloma Trial in Worldwide (bb2121)
Active, not recruiting
- Multiple Myeloma
- bb2121
-
San Francisco, California
- +47 more
Jul 18, 2022
Multiple Myeloma Trial in Worldwide (Lemzoparlimab, Dexamethasone, Carfilzomib)
Terminated
- Multiple Myeloma
- Lemzoparlimab
- +4 more
-
Tucson, Arizona
- +58 more
Jul 6, 2022
Multiple Myeloma Trial in Worldwide (Belantamab mafodotin, Pomalidomide, Dexamethasone)
Recruiting
- Multiple Myeloma
- Belantamab mafodotin
- +3 more
-
Tucson, Arizona
- +131 more
Jul 1, 2022
Lymphoma, Multiple Myeloma Trial in Worldwide (Lenalidomide, Dexamethasone, Dexamethasone (Oral))
Completed
- Lymphoma
- Multiple Myeloma
- Lenalidomide
- +4 more
-
Muscle Shoals, Alabama
- +215 more
May 5, 2022